ReP USP - Resultado da busca

Artigo de periodico
Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease (2020)
Schaab, Estela Hanauer; Lanchote, Vera Lucia ; Nardotto, Glauco Henrique Balthazar ; Pereira, Maria Paula Marques ; Dantas, Márcio ; Paiva, Carlos Eduardo; Coelho, Eduardo Barbosa
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: NEFROPATIAS, INTERAÇÃO ENTRE ALIMENTOS E MEDICAMENTOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHAAB, Estela Hanauer; LANCHOTE, Vera Lucia; NARDOTTO, Glauco Henrique Balthazar; et al. Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease. The Journal of Clinical Pharmacology, Hoboken, v. 60, n. 1, p. 75-85, 2020. Disponível em: < https://doi.org/10.1002/jcph.1485 > DOI: 10.1002/jcph.1485.
APA
Schaab, E. H., Lanchote, V. L., Nardotto, G. H. B., Pereira, M. P. M., Dantas, M., Paiva, C. E., & Coelho, E. B. (2020). Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease. The Journal of Clinical Pharmacology, 60( 1), 75-85. doi:10.1002/jcph.1485
NLM
Schaab EH, Lanchote VL, Nardotto GHB, Pereira MPM, Dantas M, Paiva CE, Coelho EB. Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 1): 75-85.Available from: https://doi.org/10.1002/jcph.1485
Vancouver
Schaab EH, Lanchote VL, Nardotto GHB, Pereira MPM, Dantas M, Paiva CE, Coelho EB. Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 1): 75-85.Available from: https://doi.org/10.1002/jcph.1485
Artigo de periodico
Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients (2020)
Ximenez, João Paulo Bianchi ; Bello, Marcelo A.; Iocken, Fernanda H. S.; Obadia, Renata C. M.; Lanchote, Vera Lucia ; Sousa, Valéria Pereira de; Suarez-Kurtz, Guilherme
Source: Basic Clinical Pharmacology & Toxicology. Unidades: FCFRP, FMRP
Subjects: NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA, RECEPTORES DE DROGA, ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XIMENEZ, João Paulo Bianchi; BELLO, Marcelo A.; IOCKEN, Fernanda H. S.; et al. Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients. Basic Clinical Pharmacology & Toxicology, West Sussex, v. 126, n. 5, p. 432-436, 2020. Disponível em: < https://doi.org/10.1111/bcpt.13368 > DOI: 10.1111/bcpt.13368.
APA
Ximenez, J. P. B., Bello, M. A., Iocken, F. H. S., Obadia, R. C. M., Lanchote, V. L., Sousa, V. P. de, & Suarez-Kurtz, G. (2020). Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients. Basic Clinical Pharmacology & Toxicology, 126( 5), 432-436. doi:10.1111/bcpt.13368
NLM
Ximenez JPB, Bello MA, Iocken FHS, Obadia RCM, Lanchote VL, Sousa VP de, Suarez-Kurtz G. Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients [Internet]. Basic Clinical Pharmacology & Toxicology. 2020 ; 126( 5): 432-436.Available from: https://doi.org/10.1111/bcpt.13368
Vancouver
Ximenez JPB, Bello MA, Iocken FHS, Obadia RCM, Lanchote VL, Sousa VP de, Suarez-Kurtz G. Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients [Internet]. Basic Clinical Pharmacology & Toxicology. 2020 ; 126( 5): 432-436.Available from: https://doi.org/10.1111/bcpt.13368
Artigo de periodico
Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study (2020)
Moreira, Fernanda de Lima ; Marques, Maria Paula ; Duarte, Geraldo ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Subjects: FÁRMACOS, ANTIRRETROVIRAIS, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fernanda de Lima; MARQUES, Maria Paula; DUARTE, Geraldo; LANCHOTE, Vera Lucia. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, Amsterdam, v. 177, 2020. Disponível em: < https://doi.org/10.1016/j.jpba.2019.112838 > DOI: 10.1016/j.jpba.2019.112838.
APA
Moreira, F. de L., Marques, M. P., Duarte, G., & Lanchote, V. L. (2020). Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, 177. doi:10.1016/j.jpba.2019.112838
NLM
Moreira F de L, Marques MP, Duarte G, Lanchote VL. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 177Available from: https://doi.org/10.1016/j.jpba.2019.112838
Vancouver
Moreira F de L, Marques MP, Duarte G, Lanchote VL. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 177Available from: https://doi.org/10.1016/j.jpba.2019.112838
Artigo de periodico
Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy (2020)
Souza, Marília Cristina Oliveira ; Pereira, Maria Paula Marques ; Duarte, Geraldo ; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: ANESTÉSICOS, PARTO, FARMACOCINÉTICA, HIV
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Marília Cristina Oliveira; PEREIRA, Maria Paula Marques; DUARTE, Geraldo; LANCHOTE, Vera Lucia. Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy. The Journal of Clinical Pharmacology, Hoboken, v. 60, n. 5, p. 566-572, 2020. Disponível em: < https://doi.org/10.1002/jcph.1554 > DOI: 10.1002/jcph.1554.
APA
Souza, M. C. O., Pereira, M. P. M., Duarte, G., & Lanchote, V. L. (2020). Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy. The Journal of Clinical Pharmacology, 60( 5), 566-572. doi:10.1002/jcph.1554
NLM
Souza MCO, Pereira MPM, Duarte G, Lanchote VL. Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 5): 566-572.Available from: https://doi.org/10.1002/jcph.1554
Vancouver
Souza MCO, Pereira MPM, Duarte G, Lanchote VL. Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 5): 566-572.Available from: https://doi.org/10.1002/jcph.1554
Artigo de periodico
Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin (2019)
Godoy, Ana Leonor Pardo Campos; Moraes, Natália Valadares de; Benzi, Jhohann Richard de Lima; Lanchote, Vera Lucia
Source: European Journal of Pharmaceutical Sciences. Unidade: FCFRP
Subjects: DIABETES MELLITUS, ANALGÉSICOS, GLICOSE, INSULINA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Ana Leonor Pardo Campos; MORAES, Natália Valadares de; BENZI, Jhohann Richard de Lima; LANCHOTE, Vera Lucia. Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin. European Journal of Pharmaceutical Sciences, Amsterdam, v. 128, p. 97-102, 2019. Disponível em: < https://doi.org/10.1016/j.ejps.2018.11.032 > DOI: 10.1016/j.ejps.2018.11.032.
APA
Godoy, A. L. P. C., Moraes, N. V. de, Benzi, J. R. de L., & Lanchote, V. L. (2019). Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin. European Journal of Pharmaceutical Sciences, 128, 97-102. doi:10.1016/j.ejps.2018.11.032
NLM
Godoy ALPC, Moraes NV de, Benzi JR de L, Lanchote VL. Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin [Internet]. European Journal of Pharmaceutical Sciences. 2019 ; 128 97-102.Available from: https://doi.org/10.1016/j.ejps.2018.11.032
Vancouver
Godoy ALPC, Moraes NV de, Benzi JR de L, Lanchote VL. Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin [Internet]. European Journal of Pharmaceutical Sciences. 2019 ; 128 97-102.Available from: https://doi.org/10.1016/j.ejps.2018.11.032
Artigo de periodico
Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women (2019)
Carvalho, Daniela Miarelli; Lanchote, Vera Lucia; Filgueira, Gabriela Campos de Oliveira; Nardotto, Glauco Henrique Balthazar; Duarte, Geraldo; Cavalli, Ricardo Carvalho; Moisés, Elaine Christine Dantas
Source: Clinical Pharmacology and Therapeutics. Unidades: FCFRP, FMRP
Subjects: FARMACOCINÉTICA CLÍNICA, PLACENTA, ANTIDEPRESSIVOS, GESTANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Daniela Miarelli; LANCHOTE, Vera Lucia; FILGUEIRA, Gabriela Campos de Oliveira; et al. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women. Clinical Pharmacology and Therapeutics, Hoboken, v. 105, n. 4, p. 1003-1008, 2019. Disponível em: < http://dx.doi.org/10.1002/cpt.1263 > DOI: 10.1002/cpt.1263.
APA
Carvalho, D. M., Lanchote, V. L., Filgueira, G. C. de O., Nardotto, G. H. B., Duarte, G., Cavalli, R. C., & Moisés, E. C. D. (2019). Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women. Clinical Pharmacology and Therapeutics, 105( 4), 1003-1008. doi:10.1002/cpt.1263
NLM
Carvalho DM, Lanchote VL, Filgueira GC de O, Nardotto GHB, Duarte G, Cavalli RC, Moisés ECD. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women [Internet]. Clinical Pharmacology and Therapeutics. 2019 ; 105( 4): 1003-1008.Available from: http://dx.doi.org/10.1002/cpt.1263
Vancouver
Carvalho DM, Lanchote VL, Filgueira GC de O, Nardotto GHB, Duarte G, Cavalli RC, Moisés ECD. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women [Internet]. Clinical Pharmacology and Therapeutics. 2019 ; 105( 4): 1003-1008.Available from: http://dx.doi.org/10.1002/cpt.1263
Artigo de periodico
Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer (2019)
Souza, Marília Cristina Oliveira; Marques, Maria Paula; Duarte, Geraldo; Lanchote, Vera Lúcia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Assunto: ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Marília Cristina Oliveira; MARQUES, Maria Paula; DUARTE, Geraldo; LANCHOTE, Vera Lúcia. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer. Journal of Pharmaceutical and Biomedical Analysis, Amsterdam, v. 164, p. 268-275, 2019. Disponível em: < http://dx.doi.org/10.1016/j.jpba.2018.10.040 > DOI: 10.1016/j.jpba.2018.10.040.
APA
Souza, M. C. O., Marques, M. P., Duarte, G., & Lanchote, V. L. (2019). Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer. Journal of Pharmaceutical and Biomedical Analysis, 164, 268-275. doi:10.1016/j.jpba.2018.10.040
NLM
Souza MCO, Marques MP, Duarte G, Lanchote VL. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 268-275.Available from: http://dx.doi.org/10.1016/j.jpba.2018.10.040
Vancouver
Souza MCO, Marques MP, Duarte G, Lanchote VL. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 268-275.Available from: http://dx.doi.org/10.1016/j.jpba.2018.10.040
Artigo de periodico
LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses (2019)
Cusinato, Diego Alberto Ciscato ; Filgueira, Gabriela Campos de Oliveira ; Rocha, Adriana; Cintra, Monica Akissue de Camargo Teixeira; Lanchote, Vera Lucia ; Coelho, Eduardo Barbosa
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: CROMATOGRAFIA LÍQUIDA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUSINATO, Diego Alberto Ciscato; FILGUEIRA, Gabriela Campos de Oliveira; ROCHA, Adriana; et al. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses. Journal of Pharmaceutical and Biomedical Analysis, Amsterdam, v. 164, p. 430-441, 2019. Disponível em: < https://doi.org/10.1016/j.jpba.2018.10.029 > DOI: 10.1016/j.jpba.2018.10.029.
APA
Cusinato, D. A. C., Filgueira, G. C. de O., Rocha, A., Cintra, M. A. de C. T., Lanchote, V. L., & Coelho, E. B. (2019). LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses. Journal of Pharmaceutical and Biomedical Analysis, 164, 430-441. doi:10.1016/j.jpba.2018.10.029
NLM
Cusinato DAC, Filgueira GC de O, Rocha A, Cintra MA de CT, Lanchote VL, Coelho EB. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 430-441.Available from: https://doi.org/10.1016/j.jpba.2018.10.029
Vancouver
Cusinato DAC, Filgueira GC de O, Rocha A, Cintra MA de CT, Lanchote VL, Coelho EB. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 430-441.Available from: https://doi.org/10.1016/j.jpba.2018.10.029
Artigo de periodico
Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis (2019)
Arroyo, Gianfranco; Bustos, Javier A.; Lescano, Andres G.; Gonzales, Isidro; Saavedra, Herbert; Rodriguez, Silvia; Pretell, E. Javier; Bonato, Pierina Sueli; Lanchote, Vera Lucia ; Takayanagui, Osvaldo Massaiti ; Horton, John; Gonzalez, Armando E.; Gilman, Robert H.; Garcia, Hector H.
Source: Clinical Infectious Diseases. Unidades: FCFRP, FMRP
Subjects: NEUROCISTICERCOSE, ANTIPARASITÁRIOS, ANTI-HELMÍNTICOS, CISTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARROYO, Gianfranco; BUSTOS, Javier A.; LESCANO, Andres G.; et al. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis. Clinical Infectious Diseases, Cary, v. 69, n. 11, p. 1996-2002, 2019. Disponível em: < http://dx.doi.org/10.1093/cid/ciz085 > DOI: 10.1093/cid/ciz085.
APA
Arroyo, G., Bustos, J. A., Lescano, A. G., Gonzales, I., Saavedra, H., Rodriguez, S., et al. (2019). Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis. Clinical Infectious Diseases, 69( 11), 1996-2002. doi:10.1093/cid/ciz085
NLM
Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Rodriguez S, Pretell EJ, Bonato PS, Lanchote VL, Takayanagui OM, Horton J, Gonzalez AE, Gilman RH, Garcia HH. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis [Internet]. Clinical Infectious Diseases. 2019 ; 69( 11): 1996-2002.Available from: http://dx.doi.org/10.1093/cid/ciz085
Vancouver
Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Rodriguez S, Pretell EJ, Bonato PS, Lanchote VL, Takayanagui OM, Horton J, Gonzalez AE, Gilman RH, Garcia HH. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis [Internet]. Clinical Infectious Diseases. 2019 ; 69( 11): 1996-2002.Available from: http://dx.doi.org/10.1093/cid/ciz085
Artigo de periodico
Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose (2019)
Cestari, Roberta Natália; Rocha, Adriana; Marques, Maria Paula da Costa ; Oliveira, Renê Donizeti Ribeiro de; Lanchote, Vera Lucia
Source: Journal of Chromatography B. Unidades: FCFRP, FMRP
Subjects: ESTATINAS, METABÓLITOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESTARI, Roberta Natália; ROCHA, Adriana; MARQUES, Maria Paula da Costa; OLIVEIRA, Renê Donizeti Ribeiro de; LANCHOTE, Vera Lucia. Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose. Journal of Chromatography B, Amsterdam, v. 1126-1127, 2019. Disponível em: < https://doi.org/10.1016/j.jchromb.2019.121766 > DOI: 10.1016/j.jchromb.2019.121766.
APA
Cestari, R. N., Rocha, A., Marques, M. P. da C., Oliveira, R. D. R. de, & Lanchote, V. L. (2019). Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose. Journal of Chromatography B, 1126-1127. doi:10.1016/j.jchromb.2019.121766
NLM
Cestari RN, Rocha A, Marques MP da C, Oliveira RDR de, Lanchote VL. Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose [Internet]. Journal of Chromatography B. 2019 ; 1126-1127Available from: https://doi.org/10.1016/j.jchromb.2019.121766
Vancouver
Cestari RN, Rocha A, Marques MP da C, Oliveira RDR de, Lanchote VL. Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose [Internet]. Journal of Chromatography B. 2019 ; 1126-1127Available from: https://doi.org/10.1016/j.jchromb.2019.121766
Trabalho de evento-anais periodico
Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients (2019)
Ximenez, João Paulo Bianchi ; Andrade, Jurandyr Moreira de ; Marques, Maria Paula da Costa ; Coelho, Eduardo Barbosa ; Suarez-Kurtz, Guilherme ; Lanchote, Vera Lucia
Source: BMC Pharmacology and Toxicology. Conference titles: Latin American Congress of Clinical and Laboratorial Toxicology - ToxiLatin. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, RECEPTORES DE DROGA, QUIMIOTERAPIA, ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XIMENEZ, João Paulo Bianchi; ANDRADE, Jurandyr Moreira de; MARQUES, Maria Paula da Costa; et al. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients. BMC Pharmacology and Toxicology[S.l: s.n.], 2019.Disponível em: DOI: 10.1186/s40360-019-0358-y.
APA
Ximenez, J. P. B., Andrade, J. M. de, Marques, M. P. da C., Coelho, E. B., Suarez-Kurtz, G., & Lanchote, V. L. (2019). Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients. BMC Pharmacology and Toxicology. London. doi:10.1186/s40360-019-0358-y
NLM
Ximenez JPB, Andrade JM de, Marques MP da C, Coelho EB, Suarez-Kurtz G, Lanchote VL. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients [Internet]. BMC Pharmacology and Toxicology. 2019 ; 20 [10] .Available from: https://doi.org/10.1186/s40360-019-0358-y
Vancouver
Ximenez JPB, Andrade JM de, Marques MP da C, Coelho EB, Suarez-Kurtz G, Lanchote VL. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients [Internet]. BMC Pharmacology and Toxicology. 2019 ; 20 [10] .Available from: https://doi.org/10.1186/s40360-019-0358-y
Artigo de periodico
UPLC-MS/MS method for gemfibrozil determination in plasma with application to a pharmacokinetic study in healthy Brazilian volunteers (2019)
Cestari, Roberta Natália; Rocha, Adriana; Oliveira, Renê Donizeti Ribeiro de; Lanchote, Vera Lucia
Source: Journal of Chromatography B. Unidades: FCFRP, FMRP
Subjects: PLASMA, FARMACOCINÉTICA, ESTUDOS DE VALIDAÇÃO, DISLIPIDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESTARI, Roberta Natália; ROCHA, Adriana; OLIVEIRA, Renê Donizeti Ribeiro de; LANCHOTE, Vera Lucia. UPLC-MS/MS method for gemfibrozil determination in plasma with application to a pharmacokinetic study in healthy Brazilian volunteers. Journal of Chromatography B, Amsterdam, v. 1125, 2019. Disponível em: < https://doi.org/10.1016/j.jchromb.2019.121712 > DOI: 10.1016/j.jchromb.2019.121712.
APA
Cestari, R. N., Rocha, A., Oliveira, R. D. R. de, & Lanchote, V. L. (2019). UPLC-MS/MS method for gemfibrozil determination in plasma with application to a pharmacokinetic study in healthy Brazilian volunteers. Journal of Chromatography B, 1125. doi:10.1016/j.jchromb.2019.121712
NLM
Cestari RN, Rocha A, Oliveira RDR de, Lanchote VL. UPLC-MS/MS method for gemfibrozil determination in plasma with application to a pharmacokinetic study in healthy Brazilian volunteers [Internet]. Journal of Chromatography B. 2019 ; 1125Available from: https://doi.org/10.1016/j.jchromb.2019.121712
Vancouver
Cestari RN, Rocha A, Oliveira RDR de, Lanchote VL. UPLC-MS/MS method for gemfibrozil determination in plasma with application to a pharmacokinetic study in healthy Brazilian volunteers [Internet]. Journal of Chromatography B. 2019 ; 1125Available from: https://doi.org/10.1016/j.jchromb.2019.121712
Artigo de periodico
Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach (2019)
Cusinato, Diego Alberto Ciscato ; Martinez, Edson Zangiacomi ; Cintra, Mônica T. C.; Filgueira, Gabriela Campos de Oliveira ; Berretta, Andresa A.; Lanchote, Vera Lucia ; Coelho, Eduardo Barbosa
Source: Journal of Ethnopharmacology. Unidades: FMRP, FCFRP
Subjects: PRÓPOLIS, FÁRMACOS DE ORIGEM ANIMAL, METABOLISMO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUSINATO, Diego Alberto Ciscato; MARTINEZ, Edson Zangiacomi; CINTRA, Mônica T. C.; et al. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach. Journal of Ethnopharmacology, Limerick, v. 245, 2019. Disponível em: < http://dx.doi.org/10.1016/j.jep.2019.112174 > DOI: 10.1016/j.jep.2019.112174.
APA
Cusinato, D. A. C., Martinez, E. Z., Cintra, M. T. C., Filgueira, G. C. de O., Berretta, A. A., Lanchote, V. L., & Coelho, E. B. (2019). Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach. Journal of Ethnopharmacology, 245. doi:10.1016/j.jep.2019.112174
NLM
Cusinato DAC, Martinez EZ, Cintra MTC, Filgueira GC de O, Berretta AA, Lanchote VL, Coelho EB. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach [Internet]. Journal of Ethnopharmacology. 2019 ; 245Available from: http://dx.doi.org/10.1016/j.jep.2019.112174
Vancouver
Cusinato DAC, Martinez EZ, Cintra MTC, Filgueira GC de O, Berretta AA, Lanchote VL, Coelho EB. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach [Internet]. Journal of Ethnopharmacology. 2019 ; 245Available from: http://dx.doi.org/10.1016/j.jep.2019.112174
Artigo de periodico
Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women (2018)
Ribeiro, Rodrigo Metzker Pereira; Moreira, Fernanda de Lima; Moisés, Elaine Christine Dantas; Cavalli, Ricardo de Carvalho; Quintana, Silvana Maria; Lanchote, Vera Lúcia; Duarte, Geraldo
Source: British Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOLOGIA, ANTIRRETROVIRAIS, SANGUE, CORDÃO UMBILICAL, VÍRUS, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Rodrigo Metzker Pereira; MOREIRA, Fernanda de Lima; MOISÉS, Elaine Christine Dantas; et al. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women. British Journal of Clinical Pharmacology, Oxford, v. 84, n. 10, p. 2415-2421, 2018. Disponível em: < http://dx.doi.org/10.1111/bcp.13700 > DOI: 10.1111/bcp.13700.
APA
Ribeiro, R. M. P., Moreira, F. de L., Moisés, E. C. D., Cavalli, R. de C., Quintana, S. M., Lanchote, V. L., & Duarte, G. (2018). Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women. British Journal of Clinical Pharmacology, 84( 10), 2415-2421. doi:10.1111/bcp.13700
NLM
Ribeiro RMP, Moreira F de L, Moisés ECD, Cavalli R de C, Quintana SM, Lanchote VL, Duarte G. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women [Internet]. British Journal of Clinical Pharmacology. 2018 ; 84( 10): 2415-2421.Available from: http://dx.doi.org/10.1111/bcp.13700
Vancouver
Ribeiro RMP, Moreira F de L, Moisés ECD, Cavalli R de C, Quintana SM, Lanchote VL, Duarte G. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women [Internet]. British Journal of Clinical Pharmacology. 2018 ; 84( 10): 2415-2421.Available from: http://dx.doi.org/10.1111/bcp.13700
Artigo de periodico
Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers (2018)
Antunes, Natalícia de Jesus; Wichert-Ana, Lauro ; Coelho, Eduardo Barbosa ; Della Pasqua, Oscar; Alexandre Júnior, Veriano; Takayanagui, Osvaldo Massaiti ; Marques, Maria Paula da Costa ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Subjects: ANTICONVULSIVANTES, FARMACOCINÉTICA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalícia de Jesus; WICHERT-ANA, Lauro; COELHO, Eduardo Barbosa; et al. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, London, v. 149, p. 442-447, 2018. Disponível em: < http://dx.doi.org/10.1016/j.jpba.2017.11.041 > DOI: 10.1016/j.jpba.2017.11.041.
APA
Antunes, N. de J., Wichert-Ana, L., Coelho, E. B., Della Pasqua, O., Alexandre Júnior, V., Takayanagui, O. M., et al. (2018). Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, 149, 442-447. doi:10.1016/j.jpba.2017.11.041
NLM
Antunes N de J, Wichert-Ana L, Coelho EB, Della Pasqua O, Alexandre Júnior V, Takayanagui OM, Marques MP da C, Lanchote VL. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2018 ; 149 442-447.Available from: http://dx.doi.org/10.1016/j.jpba.2017.11.041
Vancouver
Antunes N de J, Wichert-Ana L, Coelho EB, Della Pasqua O, Alexandre Júnior V, Takayanagui OM, Marques MP da C, Lanchote VL. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2018 ; 149 442-447.Available from: http://dx.doi.org/10.1016/j.jpba.2017.11.041
Trabalho de evento-resumo
Effects of maternal obesity on the delivery outcome during labor induction with misoprostol (2017)
Filgueira, G.; Filgueira, O.; Carvalho, D.; Marques, M.; Rocha, A.; Moisés, Elaine Christine Dantas; Duarte, Geraldo; Lanchote, Vera Lúcia; Cavalli, Ricardo de Carvalho
Source: Abstracts. Conference titles: World Congress on Maternal Fetal Neonatal Medicine. Unidades: FMRP, FCFRP
Subjects: OBESIDADE, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, G.; FILGUEIRA, O.; CARVALHO, D.; et al. Effects of maternal obesity on the delivery outcome during labor induction with misoprostol. Anais.. London: [s.n.], 2017.
APA
Filgueira, G., Filgueira, O., Carvalho, D., Marques, M., Rocha, A., Moisés, E. C. D., et al. (2017). Effects of maternal obesity on the delivery outcome during labor induction with misoprostol. In Abstracts. London.
NLM
Filgueira G, Filgueira O, Carvalho D, Marques M, Rocha A, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Effects of maternal obesity on the delivery outcome during labor induction with misoprostol. Abstracts. 2017 ;
Vancouver
Filgueira G, Filgueira O, Carvalho D, Marques M, Rocha A, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Effects of maternal obesity on the delivery outcome during labor induction with misoprostol. Abstracts. 2017 ;
Artigo de periodico
The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries (2017)
Costa, A. C. C.; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia; Correia, B. V.; Abumansur, Juliana Trench; Lauretti, Gabriela Rocha; Moraes, N. V. de
Source: European Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOGENÉTICA, FARMACOCINÉTICA, POLIMORFISMO, BLOQUEIO NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, A. C. C.; COELHO, Eduardo Barbosa; LANCHOTE, Vera Lúcia; et al. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, Berlin, v. 73, n. 8, p. 957-963, 2017. Disponível em: < http://dx.doi.org/10.1007/s00228-017-2243-1 > DOI: 10.1007/s00228-017-2243-1.
APA
Costa, A. C. C., Coelho, E. B., Lanchote, V. L., Correia, B. V., Abumansur, J. T., Lauretti, G. R., & Moraes, N. V. de. (2017). The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, 73( 8), 957-963. doi:10.1007/s00228-017-2243-1
NLM
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.Available from: http://dx.doi.org/10.1007/s00228-017-2243-1
Vancouver
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.Available from: http://dx.doi.org/10.1007/s00228-017-2243-1
Artigo de periodico
Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients (2017)
Nardotto, Glauco H. B; Lanchote, Vera Lúcia; Coelho, Eduardo Barbosa; Della Pasqua, Oscar
Source: European Journal of Pharmaceutical Sciences. Unidades: FCFRP, FMRP
Subjects: FARMACOLOGIA, DIABETES MELLITUS, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDOTTO, Glauco H. B; LANCHOTE, Vera Lúcia; COELHO, Eduardo Barbosa; DELLA PASQUA, Oscar. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients. European Journal of Pharmaceutical Sciences, Amsterdam, v. 109S, p. S108-S115, 2017. Disponível em: < http://dx.doi.org/10.1016/j.ejps.2017.05.033 > DOI: 10.1016/j.ejps.2017.05.033.
APA
Nardotto, G. H. B., Lanchote, V. L., Coelho, E. B., & Della Pasqua, O. (2017). Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients. European Journal of Pharmaceutical Sciences, 109S, S108-S115. doi:10.1016/j.ejps.2017.05.033
NLM
Nardotto GHB, Lanchote VL, Coelho EB, Della Pasqua O. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109S S108-S115.Available from: http://dx.doi.org/10.1016/j.ejps.2017.05.033
Vancouver
Nardotto GHB, Lanchote VL, Coelho EB, Della Pasqua O. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109S S108-S115.Available from: http://dx.doi.org/10.1016/j.ejps.2017.05.033
Artigo de periodico
Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis (2017)
Castro, Francine Attié de; Simões, Belinda Pinto; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: CITOCINAS, FÁRMACOS IMUNOSSUPRESSORES, ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Francine Attié de; SIMÕES, Belinda Pinto; COELHO, Eduardo Barbosa; LANCHOTE, Vera Lúcia. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis. The Journal of Clinical Pharmacology, Oxford, v. 57, n. 6, p. 784-795, 2017. Disponível em: < http://dx.doi.org/10.1002/jcph.863 > DOI: 10.1002/jcph.863.
APA
Castro, F. A. de, Simões, B. P., Coelho, E. B., & Lanchote, V. L. (2017). Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis. The Journal of Clinical Pharmacology, 57( 6), 784-795. doi:10.1002/jcph.863
NLM
Castro FA de, Simões BP, Coelho EB, Lanchote VL. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 784-795.Available from: http://dx.doi.org/10.1002/jcph.863
Vancouver
Castro FA de, Simões BP, Coelho EB, Lanchote VL. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 784-795.Available from: http://dx.doi.org/10.1002/jcph.863
Artigo de periodico
Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac (2017)
Silva, Carolina de Miranda; Rocha, Adriana; Tozatto, Eduardo; Silva, Lucienir Maria da; Donadi, Eduardo Antônio; Costa, Teresa Dalla; Lanchote, Vera Lúcia; Schmidt, Stephan; Bulitta, Jürgen B.
Source: The AAPS Journal. Unidades: FCFRP, FMRP
Subjects: FARMACODINÂMICA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Carolina de Miranda; ROCHA, Adriana; TOZATTO, Eduardo; et al. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac. The AAPS Journal, Arlington, v. 19, n. 6, p. 1814-1825, 2017. Disponível em: < http://dx.doi.org/10.1208/s12248-017-0138-9 > DOI: 10.1208/s12248-017-0138-9.
APA
Silva, C. de M., Rocha, A., Tozatto, E., Silva, L. M. da, Donadi, E. A., Costa, T. D., et al. (2017). Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac. The AAPS Journal, 19( 6), 1814-1825. doi:10.1208/s12248-017-0138-9
NLM
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Costa TD, Lanchote VL, Schmidt S, Bulitta JB. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac [Internet]. The AAPS Journal. 2017 ; 19( 6): 1814-1825.Available from: http://dx.doi.org/10.1208/s12248-017-0138-9
Vancouver
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Costa TD, Lanchote VL, Schmidt S, Bulitta JB. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac [Internet]. The AAPS Journal. 2017 ; 19( 6): 1814-1825.Available from: http://dx.doi.org/10.1208/s12248-017-0138-9

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration

Keywords